|Home | About | Journals | Submit | Contact Us | Français|
Beginning with this issue Molecular Oncology introduces a new type of publication – Thematic Issues – that are intended to highlight a particular area of cancer research and to give an overview of where that specific field stands today and where it is heading to in the near future. The rational for introducing this new type of publication was prompted largely by the staggering expansion both in knowledge and technology in various areas of cancer research. These developments call for a forum in which new discoveries and future perspectives are integrated and presented in a timely manner.
The focus of this first Thematic Issue is ovarian cancer, the most deadly gynecological malignancy. The Issue, which has been edited by Patricia Tonin from the Department of Human Genetics, McGill University, Montreal, Canada, covers various topical areas in ovarian cancer research and is supplemented with News and Views items.
We appreciate suggestions for future topics, and if you would like to organize a Thematic Issue you are welcome to send me a proposal with a brief outline of its content (MolOnc@cancer.dk). Thematic Issues usually contain 6–8 reviews (maximum 10 000 words including references and figure legends); there are no page charges and colour is free. Guest editors are expected to organize the content of the Issue and to coordinate the review process. In this way we secure homogeneity as well as a speedy handling of the contributions.
With over 3500 online subscribers already having access to Molecular Oncology worldwide, you are likely to have access to this interesting thematic issue. You can find the journal on Sciencedirect – http://www.sciencedirect.com/science/journal/15747891 or through the citation database Scopus – http://www.scopus.com.
I would like to take this opportunity to express my gratitude to all of those that contributed to the Issue and in particular to Patricia Tonin for her commitment and dedication.
Celis Julio E., (2009), Thematic Issues, Molecular Oncology, 3, doi: 10.1016/j.molonc.2009.01.007.